Keywords: s-p, takes, 150m, charge, restates, earnings, drug
S-P takes $150M charge, restates 2002 earnings
Article | 03 March 2003
US drug major Schering-Plough has revised its fourth-quarter andfull-year 2002 earnings downwards after the company elected to take a further $150 million ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
